Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
149.2 USD | +3.53% | +12.50% | -17.69% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.